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ABSTRACT 
Background 
The ‘two-week rule’ (TWR) fast-track cancer referral system for head and neck cancers was 
introduced by the UK government in 2000, to facilitate earlier diagnosis. However, little work has 
compared stage on diagnosis of cancer before and after the implementation of the system. 
Objectives 
(1) Describe the presentation of oral cancer in Merseyside from 1992-2012. 
(2) To evaluate whether stage on presentation has improved after the introduction of the TWR 
using data from a clinical database in Merseyside 1992-2012. 
(3) To assess the relationship between stage on presentation and social deprivation 1992-2012; 
(4) To assess the change in presentation for different sites within the oral cavity. 
Method and setting 
Patients were identified using the Aintree (Liverpool) head and neck oncology database, containing 
all diagnoses of oral squamous cell carcinoma (SCC) between 1992 – 2012.  Cancers were clinically 
staged using the American Joint Committee on Cancer (AJCC) stage groupings and divided into ‘early’ 
(stage 1 and 2) and ‘late’ (stage 3 and 4). Index of Multiple Deprivation (IMD) 2004 data were 
derived from patient postcodes. Appropriate regression analyses were undertaken. 
Results 
1485 consecutive patients diagnosed were studied.  Median (IQR) age was 63 (55-73) years and 61% 
were male. 36% of cancers were located on anterior 2/3rds tongue, 30% floor of mouth, and 34% 
elsewhere. 
 ‘Late’ tumour presentation was 52% (95%CI 46.8-56.4%) for 1992-2000, and 44% (95%CI 41.4-
47.5%) for 2001-2012 (P=0.01). Joinpoint regression analysis of ‘late’ presentation indicated a steady 
fall 1992-2012, at an annual percentage decrease of 1.27% (95% CI -2.3 to -0.2). No statistically 
significant change in trend was identified either overall or within deprivation groups following the 
TWR.  
For patients in ‘more deprived’ neighbourhoods, ‘late’ tumour presentation was:  56% and 47%; in 
‘less deprived’ areas: 48% and 42%, before and after the introduction of the TWR, respectively.   
Year of diagnosis, tumour site and IMD2004 were significantly associated with ‘late’ presentation, 
and location of tumour was also associated with time period and IMD2004.  
 Main conclusions 
Stage on presentation improved between 1992-2012. Joinpoint analysis showed no significant 
change in trend following the introduction of the TWR. The rate of improvement was highest for 
most deprived; nevertheless, deprivation inequality persists and this should be a focus of further 
initiatives and research. 
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INTRODUCTION 
 
In 1995, the first EUROCARE studies were published1. These studies indicated that outcomes for 
some cancers in the UK were worse than the best-performing European countries.  More recently, 
the EUROCARE-5 studies2 indicated that for head and neck cancer, UK 5-year survival rates compare 
well with the best in Europe yet 1-year survival rates are still worse than several European countries, 
suggesting a higher incidence of cancers presenting at an advanced stage in the UK. There is a broad 
consensus that the relatively poor UK performance in cancer is genuine3. 
Oral cancer is the sixth most common cancer in the world4 and approximately 6500 cases are 
diagnosed per year in the UK5. The survival of oral cancer is poor, with overall 5-year survival rates in 
the order of 50%, having remained much the same for the past 50 years despite advances in both 
surgery and radiotherapy5, 6.  For head and neck cancer, including oral cancer, studies clearly show 
the correlation between stage on diagnosis and outcome7,8. Furthermore, treatment of stage 1 and 
2 cancers is considerably less extensive than for more advanced disease; for example, sentinel node 
biopsy may preclude the need for neck dissection in early cancers and complex reconstruction, with 
associated morbidity, may often be avoided9. 
The ‘two-week rule’ (TWR) or ‘two-week wait’ (TWW) fast-track cancer referral system was 
introduced by the UK government in 1999 for breast cancer and for all other cancers in 2000 as part 
of the NHS Cancer Plan10. The rule requires that all cases of suspected cancer referred to secondary 
care by a primary care clinician are assessed by a specialist within 14 days, with the aim of 
encouraging early diagnosis. This process is facilitated by a set of National Institute for Health and 
Care Excellence (‘NICE’) guidelines for primary care practitioners, one set for each cancer type. The 
2004 guidelines11 were revised and updated in 201512. 
Harrison and Foot13 note: ‘for the two-week rule to be effective……the stage at which patients were 
identified should have fallen since its introduction’.  However, whilst much published research has 
focused on the process of cancer referral via the TWR, there is relatively little evidence, for all cancer 
types, on whether the introduction of the TWR and NICE associated guidance has resulted in 
improved survival or whether cancer cases are presenting at an earlier stage. For oral cancer there is 
very little such evidence14. Data from the National Cancer Registration and Analysis Service (NCRAS) 
on oral cancer indicate that between 2006 and 2013 there was little difference in 1-year survival 
between TWR referrals and other ‘routine’ referrals (77% vs 78%), but emergency presentations did 
considerably worse (44%).  During the same period, 34% of cases presented via the TWR system 
whilst 6% presented as emergencies. The proportion of oral cancers presenting via the TWR also 
steadily increased from 24% in 2006 to 33% in 201215.  
In addition to improving overall cancer survival, a key UK government health focus is the relationship 
of social inequalities and cancer16, 17.  Socio-economic differences in survival from head and neck 
cancers are among the largest of any malignancies18. Oral cancer has a well-established link to social 
deprivation and is known to have both increased incidence and poorer outcome for the more 
socially deprived19. 
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This study aims to: 
(1) Describe the presentation of oral cancer in Merseyside from 1992-2012. 
(2) Evaluate the stage on presentation of oral cancers in Merseyside from 1992 to 2012. 
comparing the periods before and after the introduction of the TWR and NICE guidance in 
2000.  
(3) Study the relationship of stage on presentation to social deprivation from 1992 to 2012, 
comparing the periods before and after the introduction of the TWR in 2000. 
(4) Examine the changes in stage on presentation in relation to different intra-oral sites. 
 
 METHODS 
 
Data source 
Patients were identified using the Aintree (Liverpool) head and neck oncology database. The Aintree 
unit, in 2012, served a population of approximately 1.9 million, including Merseyside, Warrington 
and Chester. Consecutive patients diagnosed with oral SCC (ICD CO1 - CO6) between January 1992 
and December 2012 were included. Since 1992, patients diagnosed or treated for head and neck 
cancer have been entered into this database which contains comprehensive and accurate, validated 
information on demography, staging, treatment and outcomes. This database was one of the first 
computerised databases of head and neck cancer in the UK20 and therefore is one of the few 
resources containing accurate data on presentation stage for several years prior to the inception of 
the UK TWR in 2000 and for the years following its introduction. The data included TNM staging 
using the American Joint Committee on Cancer (AJCC) standards.  Cancers were classified into group 
stages 1 to 4 using staging following clinical examination and CT/MRI scanning and further classified 
as (a) ‘early’ presentations, comprising stage 1 and 2 cases and (b) ‘late’ presentations, comprising 
stage 3 and 4 cases. In view of the marked differences in survival and treatment requirements of 
these groups, ‘early’ and ‘late’ categories for oral cancers have been utilised in much previous 
work21,22. 
Deprivation data 
Patient postcode was used to derive Index of Multiple Deprivation (IMD) data. The overall IMD is 
conceptualised as a weighted area level aggregation of several specific dimensions of deprivation. 
We decided to use IMD 200423 where possible as it incorporated data indicators relating to 2001, a 
year which is close to the centre of the period studied.   The IMD 2004 consists of seven domains 
(income deprivation, employment deprivation, health deprivation and disability, education skills and 
training deprivation, barriers to housing and services, living environment deprivation and crime) with 
each domain containing several indicators. Patient postcodes came from an amalgam of sources, 
mainly from datasets used for other studies over the time period. Checks were made against patient 
postcode using available electronic records relevant to the time the patient first presented. 
Specifically, the records for patients presenting in the two years of 1997 and 2003 were checked and 
for 84% and 90% of patients respectively their postcode was from the time they first presented.   
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Analyses 
To determine any changes in the stage-on-presentation trend, particularly following the introduction 
of the TWR, ‘Joinpoint’ Regression Program version 4.6.0.0 (Surveillance Research Program of the 
National Cancer Institute, Calverton, USA, 2018), was used to calculate the best-fitting line through 
the years of data. ‘Joinpoint’ employs an algorithm to determine whether a multiple-segmented line 
fits better than a straight line. Each line is connected by an aptly-named ‘joinpoint’ which indicates a 
statistically significant (p<0.05) change in trend. The test of significance uses a Monte Carlo 
permutation method to determine the best fit line(s) for analysis of the time series. ‘Joinpoint’ 
analyses were made for percentage of all late (stage 3 and 4) cancers and for least and most 
deprived groups. 
The Chi-squared test was used to test the association of patient groups with ‘late’ presentation.  
SPSS version 25 was used for data management, for descriptive statistics and for the Chi-squared 
tests. Binary regression (STATA binreg procedure, rr link option) was used to assess the association 
of clinical and demographic variables with late presentation (stage 3 or 4). It was also used to assess 
the association of time period (1992-2000, 2001-2012) on whether patients presented ‘late’ after 
adjustment for other factors as independent predictors and similarly the association with regard to 
IMD deprivation status. Risk ratios were estimated, as were 95% confidence intervals. 
Ethics 
Ethical review was undertaken by the Medical Sciences Inter-Divisional Research Ethics Committee 
of the University of Oxford who confirmed that the study does not require ethical approval because 
it analyses information previously collected during normal care. 
 
RESULTS 
 
Increasing numbers of oral cancers 
 
There were 1485 patients with primary oral cancers included in this study, with clinical staging 
known for 1483. From 1992 to 2012 the number of presenting oral cancers in Merseyside steadily 
increased, calculated in ‘Joinpoint’, at an annual percentage change (APC) of 5.8% (95% CI 4.5-7.1). 
The increase is neither attributable to increasing population nor marked increase in the age-groups 
associated with the highest incidence of oral cancer (Figure 1a, 1b,1c).  
 
Stage at diagnosis 
 
Over the 21-year period 438 were diagnosed 1992-2000 and 1045 diagnosed 2001-2012. (Table 1). 
The percentages presenting with late (stage 3 or 4) tumours were 52% (226/438) 95%CI 46.8-56.4%, 
for 1992-2000, and 44% (464/1045) 95%CI 41.4-47.5%, for 2001-2012, (P=0.01). 
 
Median (IQR) age at diagnosis was 63 (55-73) years and 61% (905) were male. Tumour location was 
anterior 2/3rds of tongue for 36% (529), floor of mouth for 30% (438), buccal for 18% (264), lower 
gum for 11% (160) and elsewhere for 6% (92).  
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Deprivation ‘groups’ 
 
For 1422 patients living in England (Isle of Man and Welsh patients were excluded) data were 
analysed in relation to IMD deprivation within two patient groups, the grouping split being 
determined by their median IMD2004 rank of 8261 where rank 1 is the residential neighbourhood in 
England assigned as the most deprived and rank 32482 is the least deprived neighbourhood.  For the 
“more deprived” group of patients their median (IQR) IMD rank was 1722 (400-4072), n=711; for the 
“less deprived” group this was 18450 (13155-24042), n=711. Almost all (88%, 625/711) of the 
patients within the “more deprived” group for analysis were living in the most deprived '20%’ of 
small areas in England and all but 6 in the most deprived ‘25%’.   For those in the “more deprived” 
group the percentages of late tumours were 56% (118/212) 95% CI 48.7-62.5% for 1992-2000, and 
47% (233/499) 95% CI 42.2-51.2% for 2001-2012, Chi Squared test P=0.03.  For those in the “less 
deprived” group the percentages of late tumours were 48% (99/207) 95% CI 40.9-54.9% for 1992-
2000, and 42% (211/504) 95% CI 37.5-46.3% for 2001-2012, Chi Squared test P=0.16.   
 
 
‘Joinpoint’ regression analysis 
 
‘Joinpoint’ regression analysis of ‘late’ (stage 3 or 4) presentations from 1992 to 2012 indicated a 
steady fall in the percentage of ‘late’ oral cancer over the period of the study; the annual percentage 
change (APC) was -1.27 (95% CI -2.3 to -0.2). A ‘zero joinpoint’ model was selected by the software 
indicating that no statistically significant change in trend was identified at any point in the study 
(Figure 2).  
Similar analyses were carried out for the ‘more’ and ‘less’ deprived groups (median split). For neither 
group was a statistically significant change in trend calculated. However, a greater APC was observed 
in the ‘more deprived’ group -1.66 (95%CI -3.0 to -0.3) compared to the ‘less deprived’ group -0.79 
(95% CI -2.5 to +0.9) (Figures 3a and 3b). 
 
Associations with ‘late’ presentation 
 
In binary regression, year of diagnosis, tumour site and IMD2004 grouping were significantly 
associated with ‘late’ presentation (Table 2).  
 
Year of diagnosis 
The risk ratio (95% confidence interval) for patients in the time period 2001-2012 relative to the time 
period 1992-2000 was 0.86 (0.77-0.96), P=0.009; adjustment for each other variables in Table 2 
made little difference on this risk ratio (range 0.85-0.86) apart from when adjusting for tumour 
location after which the risk ratio (95% CI) was 0.93 (0.85-1.02), P=0.13. 
 
 
 
7 
 
Deprivation 
The risk ratio (95% CI) for the 50% of patients living in the ‘most deprived’ neighbourhoods relative 
to ‘less deprived’ neighbourhoods was 1.13 (1.01-1.27), P=0.03; adjustment for each other variable 
in Table 2 made little difference on this risk ratio (range 1.13-1.16) apart from when adjusting for 
tumour location after which the risk ratio (95% CI) was 1.05 (0.96-1.15). p=0.30 
 
Site of cancer 
Almost all (84%) of lower gum tumours presented late compared to 27% of tumours of the anterior 
two-thirds of the tongue. Tumour site was associated with IMD2004 grouping (P<0.001) and 
borderline with time period (P=0.06). There was an increase in tumours of the anterior two-thirds 
tongue from 30% (132/438) during 1992-2000 to 38% (397/1045) during 2001-2012, with slight 
declines for all other locations. Patients with tumours in the floor of mouth were more likely to live 
in more deprived areas with 56% (236/425) living in the most deprived quintile of areas within 
England compared to between 30-41% for other tumour locations; also 63% (267/425) were within 
the ‘more deprived’ half of the sample compared to 35-48% for other tumour locations.  ‘Late’ 
presentation over time is shown by tumour location, IMD2004 deprivation status (median split) and 
time period in Figure 4. 
 
DISCUSSION 
Increasing numbers of oral cancers 
The increase in oral cancers identified in this study reflects the national picture; oral cancer rates in 
the UK increased by 32%-33% between 2002 and 201224. It would seem clear that much work needs 
to be done on the prevention of oral cancer. The reasons for the increase are not entirely clear. 
Smoking and alcohol are the most important causes of oral cancer in this study25. However, since the 
1970s UK smoking rates have markedly declined, although alcohol consumption has steadily 
increased from the 1960s to the present day26. More recently, oral cancers associated with human 
papilloma virus (HPV) subtype HPV-16 are becoming increasingly prevalent, especially in the oro-
pharyngeal region27. The data for this study were collected at the central head and neck unit in 
Merseyside and increasing numbers will be influenced to an extent by centralisation of the oral 
cancer service following the Calman-Hine report on cancer services28.  Nevertheless, by the mid to 
late 1990s almost all oral cancers in Merseyside were managed at the central unit and are, 
therefore, included in these data.  
Stage on presentation before and after the TWR-NICE guidance referral system 
This study found that from 1992 to 2012 the percentage of oral cancers presenting ‘late’ (stage 3 
and 4) reduced at an APC of 1.27% per year – with, of course, a corresponding increase in the 
proportion presenting ‘early’ (stage 1 and 2).  However, in this study, no marked change in the 
presentation of oral cancer was observed in the period following the introduction of the TWR 
referral system. The stage on presentation of oral cancer was improving prior to the TWR and 
continued to improve at a similar rate following its introduction. It is therefore difficult, in the light 
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of the results in this study, to define the exact effect that the introduction of the TWR has had on 
stage-on-presentation of oral cancer. 
There is very limited published work to date in relation to the effect of UK cancer policy on oral 
cancer outcomes14. Published work, in relation to several other cancer types, has presented a mixed 
picture of changes in survival trends following the implementation of the TWR and associated 
policies in the NHS Cancer Plan. A study on colorectal cancer, comparing patients referred via the 
TWR and other methods found no difference in disease stage between patients referred by each 
pathway29. A further study on colorectal cancer compared groups diagnosed before and after the 
TWR; Kaplan-Meier assessment showed no difference in 2-year survival between the groups30. A 
study on 2746 sarcoma referrals reported that the TWR had ‘no impact’ on early diagnosis31. 
Conversely, in a study on melanoma, tumours were thinner after the introduction of the TWR and 
survival improved32.  In a study of 8049 general practices in England, Moller et al33 reported that 
practices with the lowest use of fast-track referral had higher cancer mortality rates. However, in a 
large study of English cancer survival trends from 1996-2013, for 21 cancers but not including head 
and neck cancer, 26 of the cancer-sex combinations showed steady mortality improvement but with 
no significant acceleration after the Cancer Plan implementation34, a pattern reflected in relation to 
stage on diagnosis in our study. 
 
Different oral sites 
Differences were observed in the change in proportion presenting late at different oral sites. The 
most marked trend in reduction of late-stage presentation was noted in floor of mouth when 
compared to anterior tongue and other oral sites, which showed little evidence of reduction over 
time. The observation regarding floor of mouth may be attributable to reduction in smoking and 
alcohol abuse, as it is believed that there is a relationship between these factors and advanced-stage 
tongue and floor of mouth cancer35. 
 
Relationship to socio-economic deprivation 
This study identified an overall steady improvement in stage-on-diagnosis of oral cancer in 
Merseyside from 1992 to 2012 and both the least and most socially deprived groups benefited in 
this respect. Interestingly, the annual percentage change was greater for the most deprived. 
Nevertheless, despite this improvement there was a persistent gap to 2012 between the social 
groups, with a greater proportion of late disease in the most deprived. It is known that oral cancer – 
like cancer of the lung and oesophagus - is more likely to be diagnosed in socially deprived groups, 
and socio-economic difference in survival from head and neck cancers are among the largest of any 
malignancies18. Published work has shown that a ‘deprivation gap’ exists for most cancer types and 
in some cancer types – brain in men and lung in women – the gap would appear to be increasing34.  
For oral cancer, it is believed that much of the difference can be related to lifestyle factors, 
especially higher smoking rates amongst the socio-economically deprived 36. The nature of the 
causes of socio-economic differences in head and neck cancers is complex and some deprivation 
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effects on survival from head and neck cancers might be mitigated through earlier detection and 
referral18. 
 
 
STRENGTHS AND LIMITATIONS OF THIS STUDY 
 
To our knowledge, this is the first published study examining changes in stage on presentation of 
oral cancer before and after the introduction of the UK two-week rule and associated guidance for 
practitioners. The study also examines the change in stage on presentation in relation to socio-
economic deprivation. 
The study includes validated staging data for 1485 patients diagnosed with oral cancer over a 21-
year period, using the Merseyside head and neck cancer database. An important advantage of this 
database is that it includes accurate staging data from the early 1990s onwards, allowing a stage on 
presentation comparison to be made before and after the introduction of the NHS Cancer Plan and 
TWR. The data period is up to 2012 but this was considered appropriate for comparing the periods 
before and after the introduction of the TWR. We noted an increasing presentation of oral cancers in 
Merseyside consistent with the national trend; however, due to shifting referral boundaries, 
changing consultant staff and different referral patterns over a 21-year period incidence rates are 
difficult to calculate with accuracy from our data. 
The study is confined to a single unit, in a region where the incidence of oral cancer is the second-
highest in the UK37. The findings in this study may be influenced by several factors, including the 
socio-economic structure of the population and regional incidence of the disease. Whilst regions 
with similar populations are likely to reflect the outcomes of this study, a comparison with areas of 
different socio-economic structure and oral cancer incidence would be of interest and value. A 
further consideration is the fact that in the years immediately following the introduction of the TWR, 
less than 50% of head and neck cancers were diagnosed via TWR referrals, although there is 
evidence that the percentage is increasing14. 
In this study clinical staging (including MRI/CT examination when available) was used. The problem 
with clinical staging is that a small percentage of apparently N0 cases will, following neck dissection, 
demonstrate positive nodes. However, if ‘pathological’ staging is used patients treated with 
radiotherapy alone do not provide a neck specimen for pathological examination and hence their 
neck pathology remains unknown. In short, both ‘clinical’ and ‘pathological’ staging have 
disadvantages in a study of this type. For consistency, we elected to use clinical staging. 
Regarding deprivation, several versions of IMD existed during the years of the study.  We used IMD 
2004 for the entire study as it represented a wide range of years included in the study. The vast 
majority of patient postcodes were those at presentation but a minority were later. IMD focuses on 
areas but lacks sensitivity to individual deprivation. 
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CONCLUSIONS AND IMPLICATIONS 
 
This study found that the stage on presentation of oral cancer in Merseyside has steadily improved 
from 1992 to 2000. The improvement continued following the introduction of the TWR in 2001 but 
‘Joinpoint’ analysis did not demonstrate a change in trend. Improvements in stage on diagnosis were 
evident in both the least and most deprived social groups with the most deprived showing more 
rapid improvement. However, throughout the study the most deprived presented later than the 
least deprived and the ‘’gap’ persisted to the end of the study. Despite the improvement in stage on 
presentation of oral cancer, the number of cases diagnosed per year increased at an annual 
percentage change of 5.8% for the duration of the study. Amongst oral sites, the most marked 
reduction in the proportion of late cases was observed in floor of mouth cancers, possibly due to 
reduction in smoking. 
In summary, the introduction of the TWR did not make a notable difference to the steady 
improvement over time in stage on presentation. Although the rate of improvement in stage on 
presentation was greatest for the more deprived groups, deprivation inequality remains with the 
least deprived presenting with more advanced cancer and this should be a focus of further initiatives 
and research. Furthermore, in the light of the increasing incidence of oral cancer, more work needs 
to focus on the causes and prevention of the disease. 
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Table 1. Numbers of oral cancers by clinical stage, and by IMD2004 status, for the 21-year period 
 
Year 
Total 
cancer
s 
Stage 
1 
Stage 
2 
Stage 
3 
Stage 
4 
% stage 3 or 4 
(Late) cancer 
%Late stages  
(MORE DEPRIVED* 
areas) 
%Late stages  
(LESS DEPRIVED* areas) 
% n % n 
1992 34 8 12 6 8 41.2 47.4 9/19 28.6 4/14 
1993 60 6 22 12 20 53.3 60.9 14/23 44.1 15/34 
1994 41 4 10 11 16 65.9 73.7 14/19 61.9 13/21 
1995 39 5 13 6 15 53.8 41.2 7/17 68.4 13/19 
1996 56 13 17 10 16 46.4 46.9 15/32 47.8 11/23 
1997 45 11 16 7 11 40.0 47.8 11/23 36.8 7/19 
1998 50 10 16 12 12 48.0 72.2 13/18 34.5 10/29 
1999 61 14 12 7 28 57.4 56.7 17/30 56.7 17/30 
2000 52 16 7 9 20 55.8 58.1 18/31 50.0 9/18 
1992-2000 438 87 125 80 146 51.6 55.7 118/212 47.8 99/207 
2001 55 18 12 6 19 45.5 56.0 14/25 32.1 9/28 
2002 46 10 14 6 16 47.8 47.6 10/21 52.2 12/23 
2003 73 14 19 8 32 54.8 57.5 23/40 48.4 15/31 
2004 68 14 20 5 29 50.0 48.3 14/29 51.4 19/37 
2005 74 23 14 5 32 50.0 52.8 19/36 48.6 17/35 
2006 83 28 20 7 28 42.2 45.2 19/42 40.0 16/40 
2007 94 29 20 14 31 47.9 53.2 25/47 42.9 18/42 
2008 117 40 31 7 39 39.3 39.3 24/61 41.2 21/51 
2009 113 34 22 4 53 50.4 53.2 33/62 48.9 23/47 
2010 98 36 21 8 33 41.8 48.6 18/37 36.2 21/58 
2011 108 38 26 11 33 40.7 42.9 18/42 38.3 23/60 
2012 116 55 23 9 29 32.8 28.1 16/57 32.7 17/52 
2001-2012 1045 339 242 90 374 44.4 46.7 233/499 41.9 211/504 
TOTAL 1483 426 367 170 520 46.5 49.4 351/711 43.6 310/711 
 
*Comprises the 50% of patients living in ‘more deprived’ neighbourhoods, as determined by the median split of IMD2004 
ranking of the area lived in.  
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Table 2.  Clinical & demographic factors and presenting with ‘late’ (stage 3 or 4) oral 
cancer 
 
  ‘Late’ stage oral cancer   
  % n P value* Risk ratio  95% CI for Risk ratio 
 TOTAL 61 690/1483    
Year of diagnosis 1992-2000 52 226/438 
0.01 
1.00 Reference 
 2001-2012 44 464/1045 0.86 0.77-0.96 
Gender Male 48 437/905 
0.10 
1.00 Reference 
 Female 44 253/578 0.91 0.81-1.02 
Age <55 42 151/357 
0.09 
1.00 Reference 
 55-64 45 201/444 1.07 0.91-1.25 
 65-74 48 179/374 1.13 0.96-1.33 
 75-84 52 159/307 1.22 1.04-1.44 
Tumour site Buccal 55 144/264 
<0.001 
1.00 Reference 
 Lower gum 84 135/160 1.55 1.36-1.76 
 Tongue (ant 2/3) 27 144/529 0.50 0.42-0.60 
 Floor of Mouth 47 207/438 0.87 0.75-1.00 
 Other 65 60/92 1.20 0.99-1.44 
IMD2004 split by More deprived 49 351/711 
0.03 
1.13 1.01-1.27 
Median rank Less deprived 44 310/711 1.00 Reference 
IMD2004 quintiles** Rank ≤1089 52 148/286  1.47 1.21-1.78 
within sample 1090-4748 46 130/283  1.30 1.07-1.60 
Rank 1=most deprived 4749-12168 52 146/283 <0.001 1.47 1.21-1.78 
12169-20414 48 137/286  1.36 1.12-1.66 
 ≥20415 35 100/284  1.00 Reference 
IMD2004 quintiles*** Rank ≤6496 49 306/625 
<0.001 
1.65 1.27-2.16 
(England) 6497-12993 53 136/255 1.80 1.36-2.38 
Rank 1=most deprived 12994-19490 47 108/228 1.60 1.20-2.14 
19491-25985 40 69/172 1.36 0.99-1.85 
 25986-32482 30 42/142 1.00 Reference 
 
*Chi-squared test 
 
**based on an even 20% quintile split of the IMD ranks of the patients in the sample 
***based on the distribution of IMD ranks across the whole of England.  
Figure 1a Numbers of oral cancers presenting to Aintree head and neck unit by year, 1992-2012 
 
Figure 1b Merseyside population 1992-2012 
 
Figure 1c Percentages of Merseyside population 55-59 years, 60-64 years, 65-69 years and 70-74 
years 
 
Population statistics provided by Liverpool City Council 
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Figure 2 Joinpoint analysis of late presentations – percentage of oral cancers presenting ‘late’ by year 1992-2012 
 
Model selected by Joinpoint: 0 joinpoints. Annual percentage change (APC) = -1.27 (95% CI -2.3 to -0.2) 
Figure 3a Joinpoint analysis of late presentations in the 711 patients living in ‘more deprived’ areas 
 
Model selected by Joinpoint: 0 joinpoints. Annual percentage change (APC) = -1.66 (95%CI -3.0 to -0.3) 
Figure 3b Joinpoint analysis of late presentations in the 711 patients living in ‘less deprived’ areas 
 
Model selected by Joinpoint: 0 joinpoints. Annual percentage change (APC) = -0.79 (95% CI -2.5 to +0.9) 
